Clinical trial GeNeo 2.0
A study to examine the value of broad agnostic NGS panel testing using AVENIO Tumor tissue Analysis CGP kits and Foundation One Liquid CDx liquid biopsy testing for the management of patients with advanced solid tumors: a Belgian PRECISION study of the BSMO in collaboration with the Cancer Center of Sciensano : GeNeo 2.0
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional without experimental drug
|
| Academic trial | Oui |
| Sponsor | BSMO |
| BECT Identifier | BE4062025000120 |
| Last update |